Canada: Research Collaboration Sartorius Teams Up with McMaster University to Advance Virus Research
Using a state-of-the-art multi-column chromatography system provided by Sartorius Stedim Biotech, a team at McMaster University wants to “perfect” a process for the purification of therapeutic viruses that is more effective and cheaper than those currently available. This is to pave the way for new and more affordable treatments to reach patients with a variety of needs. “
Hamilton/Canada; Aubagne/France — Sartorius Stedim Biotech has entered into a partnership with McMaster University to improve manufacturing processes of antibody and virus-based treatments for diseases such as Covid-19, cancers, and genetic disorders.
“This research plans will the envelope in leading advanced, cutting-edge research in bio-manufacturing,” says John Preston, associate dean, research, innovation and external relations in the Faculty of Engineering. “Establishing industry-friendly, collaborative environments is critical in solving real-world problems.” More effective bio-manufacturing can make advanced biotherapeutics cost-effective and available to more people globally, the partners state.
David Latulippe, associate professor of Chemical Engineering, and Prashant Mhaskar, professor of Chemical Engineering and Canada Research Chair in Nonlinear and Fault-Tolerant Control, are leading this project with Sartorius Stedim Biotech. The collaboration will initially run for four years.
As part of the partnership, Sartorius Stedim Biotech will provide student training opportunities at their research and development facilities in North America and Europe. Ian Gough, a graduate of McMaster’s Chemical and Bioengineering program, has already started working on this project. Gough is a former member of the Summer Studentship Internship program from BioCanRx, a Networks of Centres of Excellence program. Claire Velikonja, a recent chemical engineering graduate from the University of Toronto, will join the team in September.